U.S. drugmakers are warning of market disruption as the Trump administration considers new trade restrictions with China and moves to tighten regulations on direct-to-consumer drug advertising.
Neurological research is making strides as scientists investigate novel pill-based treatments designed to aid brain recovery following strokes or traumatic injuries.